Evidence map›Paper›PMID 27066514›Full record

ArticleMolecular genetics & genomic medicine2016

Chromosome loci vary by juvenile myoclonic epilepsy subsyndromes: linkage and haplotype analysis applied to epilepsy and EEG 3.5-6.0 Hz polyspike waves.

Jenny E Wight, Viet-Huong Nguyen, Marco T Medina, Christopher Patterson, Reyna M Durón, Yolly Molina, Yu-Chen Lin, Iris E Martínez-Juárez, Adriana Ochoa, Aurelio Jara-Prado and 5 more

Open access · goldAbstract read
In one paragraph

Article in Molecular genetics & genomic medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Jenny E WightEpilepsy Genetics/Genomics LaboratoriesVA GLAHS - West Los AngelesLos AngelesCalifornia; GENESS International ConsortiumLos AngelesCalifornia.
Viet-Huong NguyenEpilepsy Genetics/Genomics LaboratoriesVA GLAHS - West Los AngelesLos AngelesCalifornia; GENESS International ConsortiumLos AngelesCalifornia.
Marco T MedinaGENESS International ConsortiumLos AngelesCalifornia; National Autonomous University of HondurasTegucigalpaHonduras.
Christopher PattersonEpilepsy Genetics/Genomics LaboratoriesVA GLAHS - West Los AngelesLos AngelesCalifornia; GENESS International ConsortiumLos AngelesCalifornia.
Reyna M DurónEpilepsy Genetics/Genomics LaboratoriesVA GLAHS - West Los AngelesLos AngelesCalifornia; GENESS International ConsortiumLos AngelesCalifornia; National Autonomous University of HondurasTegucigalpaHonduras; Universidad Tecnológica Centroamericana (UNITEC)TegucigalpaHonduras; Department of NeurologyDavid Geffen School of Medicine at UCLALos AngelesCalifornia.
Yolly MolinaGENESS International ConsortiumLos AngelesCalifornia; National Autonomous University of HondurasTegucigalpaHonduras.
Yu-Chen LinEpilepsy Genetics/Genomics LaboratoriesVA GLAHS - West Los AngelesLos AngelesCalifornia; GENESS International ConsortiumLos AngelesCalifornia.
Iris E Martínez-JuárezGENESS International ConsortiumLos AngelesCalifornia; National Institute of Neurology and NeurosurgeryMexico CityMexico.
Adriana OchoaGENESS International ConsortiumLos AngelesCalifornia; National Institute of Neurology and NeurosurgeryMexico CityMexico.
Aurelio Jara-PradoGENESS International ConsortiumLos AngelesCalifornia; National Institute of Neurology and NeurosurgeryMexico CityMexico.
Miyabi TanakaEpilepsy Genetics/Genomics LaboratoriesVA GLAHS - West Los AngelesLos AngelesCalifornia; GENESS International ConsortiumLos AngelesCalifornia; Department of NeurologyDavid Geffen School of Medicine at UCLALos AngelesCalifornia.
Dongsheng BaiEpilepsy Genetics/Genomics LaboratoriesVA GLAHS - West Los AngelesLos AngelesCalifornia; GENESS International ConsortiumLos AngelesCalifornia; Department of NeurologyDavid Geffen School of Medicine at UCLALos AngelesCalifornia.
Sumaya AftabEpilepsy Genetics/Genomics LaboratoriesVA GLAHS - West Los AngelesLos AngelesCalifornia; GENESS International ConsortiumLos AngelesCalifornia; Department of NeurologyDavid Geffen School of Medicine at UCLALos AngelesCalifornia.
Julia N BaileyEpilepsy Genetics/Genomics LaboratoriesVA GLAHS - West Los AngelesLos AngelesCalifornia; GENESS International ConsortiumLos AngelesCalifornia; Department of EpidemiologyFielding School of Public Health at UCLALos AngelesCalifornia.
Antonio V Delgado-EscuetaEpilepsy Genetics/Genomics LaboratoriesVA GLAHS - West Los AngelesLos AngelesCalifornia; GENESS International ConsortiumLos AngelesCalifornia; Department of NeurologyDavid Geffen School of Medicine at UCLALos AngelesCalifornia.
VA Greater Los Angeles Healthcare System · USInstituto Nacional de Neurología y Neurocirugía · MXVA West Los Angeles Medical Center · USWest Los Angeles College · USNational Autonomous University of Honduras · HNNational Autonomous University of Honduras · HN

Funding

Discovering More Juvenile Myoclonic Epilepsy Genes by a ConsortiumR01NS055057 · NINDS · BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE · PI BAILEY, JULIA N, DELGADO-ESCUETA, ANTONIO V. · 2010 to 2014
$2.4M
Persisting Grand Mal and Myoclonic Seizures in JME including VeteransI01CX000743 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI DELGADO-ESCUETA, ANTONIO V. · 2013 to 2016
–
CSRD VA I01 CX000743NHLBI NIH HHS HHSN268201200008ININDS NIH HHS R01 NS055057
6 · The paper itself

Abstract

Juvenile myoclonic epilepsy (JME), the most common genetic epilepsy, remains enigmatic because it is considered one disease instead of several diseases. We ascertained three large multigenerational/multiplex JME pedigrees from Honduras with differing JME subsyndromes, including Childhood Absence Epilepsy evolving to JME (CAE/JME; pedigree 1), JME with adolescent onset pyknoleptic absence (JME/pA; pedigree 2), and classic JME (cJME; pedigree 3). All phenotypes were validated, including symptomatic persons with various epilepsies, asymptomatic persons with EEG 3.5-6.0 Hz polyspike waves, and asymptomatic persons with normal EEGs. Two-point parametric linkage analyses were performed with 5185 single-nucleotide polymorphisms on individual pedigrees and pooled pedigrees using four diagnostic models based on epilepsy/EEG diagnoses. Haplotype analyses of the entire genome were also performed for each individual. In pedigree 1, haplotyping identified a 34 cM region in 2q21.2-q31.1 cosegregating with all affected members, an area close to 2q14.3 identified by linkage (Z max = 1.77; pedigree 1). In pedigree 2, linkage and haplotyping identified a 44 cM cosegregating region in 13q13.3-q31.2 (Z max = 3.50 at 13q31.1; pooled pedigrees). In pedigree 3, haplotyping identified a 6 cM cosegregating region in 17q12. Possible cosegregation was also identified in 13q14.2 and 1q32 in pedigree 3, although this could not be definitively confirmed due to the presence of uninformative markers in key individuals. Differing chromosome regions identified in specific JME subsyndromes may contain separate JME disease-causing genes, favoring the concept of JME as several distinct diseases. Whole-exome sequencing will likely identify a CAE/JME gene in 2q21.2-2q31.1, a JME/pA gene in 13q13.3-q31.2, and a cJME gene in 17q12.

Indexed as

Absenceelectroencephalogramendophenotypeepilepsyjuvenile myocloniclinkagepyknolepsy

Identifiers

PMID27066514
PMCPMC4799870
OpenAlexW2299950816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.